Barclays analyst Balaji Prasad raised the firm’s price target on Zoetis to $242 from $230 and keeps an Overweight rating on the shares. The company’s Q2 Q2 was “organically distraction-less,” with all key franchises delivering strong growth, the analyst tells investors in a research note. The firm says earnings growth, and not multiple expansion, should sustain the company’s stock momentum.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZTS: